Record Information |
---|
Version | 2.0 |
---|
Created at | 2009-02-03 10:14:16 UTC |
---|
Updated at | 2024-09-17 15:42:24 UTC |
---|
NP-MRD ID | NP0000610 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 17alpha,20alpha-Dihydroxypregn-4-en-3-one |
---|
Description | 17 Alpha,20alpha-Dihydroxypregn-4-en-3-one, also known as 17,20 alpha-OHP or 20alpha-dihydroxyprogesterone, is a steroid hormone that is elevated in late pregnancy. In particular, the concentration of plasma 17,20 alpha-OHP is significantly increased during the third trimester of pregnancy, and the increment continues to increase through labour and delivery (PMID:6874891 ). 17,20 Alpha-OHP is known to be a substrate for the enzyme 20alpha-hydroxysteroid dehydrogenase or 20alpha-HSD (EC 1.1.1.149). This enzyme catalyzes the following chemical reaction: 17Alpha,20alpha-dihydroxypregn-4-en-3-one + NAD(P)+ = 17alpha-hydroxyprogesterone + NAD(P)H + H+. This enzyme is actively involved in the control of progesterone homeostasis in the pregnancy of mammals. While 20alpha-HSD expression and activity is downregulated in the corpus luteum of pregnancy, 24 hours prior to parturition, ovarian 20alpha-HSD activity is acutely stimulated. 17,20 Alpha-OHP is a biologically weaker progestin. Progestin facilitates estrogen induction of the preovulatory luteinizing hormone (LH) surge. It is known that 17,20 alpha-OHP is increased at midcycle but its importance in regulating LH has not been studied. However, periovulatory levels of 17,20 alpha-OHP do not play a role in modulating the estrogen-induced bioactive LH surge (PMID:2245841 ). |
---|
Structure | [H][C@@]12CC[C@](O)([C@H](C)O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C InChI=1S/C21H32O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12-13,16-18,22,24H,4-11H2,1-3H3/t13-,16+,17-,18-,19-,20-,21-/m0/s1 |
---|
Synonyms | Value | Source |
---|
17a,20a-Dihydroxypregn-4-en-3-one | Generator | 17Α,20α-dihydroxypregn-4-en-3-one | Generator | 17-a,20-a-Dihydroxypregn-4-en-3-one | HMDB | 17-Α,20-α-dihydroxypregn-4-en-3-one | HMDB | (20S)-17,20-Dihydroxypregn-4-en-3-one | HMDB | 17 alpha, 20 alpha-OHP | HMDB | 17 alpha, 20 alpha-p | HMDB | 17,20 alpha-OHP | HMDB | 17-alpha,20-alpha-Dihydroxypregn-4-en-3-one | HMDB | 4-Pregnen-17a, 20a-diol-3-one | HMDB | 4-Pregnen-17α, 20α-diol-3-one | HMDB | 4-Pregnen-17alpha, 20alpha-diol-3-one | HMDB | 17a-Hydroxy-20a-dihydroprogesterone | HMDB | 17Α-hydroxy-20α-dihydroprogesterone | HMDB | 17alpha-Hydroxy-20alpha-dihydroprogesterone | HMDB | 20a-Dihydroxyprogesterone | HMDB | 20Α-dihydroxyprogesterone | HMDB | 20alpha-Dihydroxyprogesterone | HMDB | 17,20Α-dihydroxy-4-pregnen-3-one | HMDB | 17,20a-Dihydroxy-4-pregnen-3-one | HMDB | 17,20alpha-Dihydroxy-4-pregnen-3-one | HMDB | 17,20Α-dihydroxy-pregn-4-en-3-one | HMDB | 17,20a-Dihydroxy-pregn-4-en-3-one | HMDB | 17,20alpha-Dihydroxy-pregn-4-en-3-one | HMDB | 17Α,20α-dihydroxy-4-pregnen-3-one | HMDB | 17a,20a-Dihydroxy-4-pregnen-3-one | HMDB | 17alpha,20alpha-Dihydroxy-4-pregnen-3-one | HMDB | 17Α,20α-dihydroxypregn-4-ene-3-one | HMDB | 17a,20a-Dihydroxypregn-4-ene-3-one | HMDB | 17alpha,20alpha-Dihydroxypregn-4-ene-3-one | HMDB | 17Α,20α-dihydroxyprogesterone | HMDB | 17a,20a-Dihydroxyprogesterone | HMDB | 17alpha,20alpha-Dihydroxyprogesterone | HMDB | Pregn-4-ene-17α,20α-diol-3-one | HMDB | Pregn-4-ene-17a,20a-diol-3-one | HMDB | Pregn-4-ene-17alpha,20alpha-diol-3-one | HMDB | 17alpha,20alpha-Dihydroxypregn-4-en-3-one | ChEBI |
|
---|
Chemical Formula | C21H32O3 |
---|
Average Mass | 332.4770 Da |
---|
Monoisotopic Mass | 332.23514 Da |
---|
IUPAC Name | (1S,2R,10R,11S,14R,15S)-14-hydroxy-14-[(1S)-1-hydroxyethyl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
Traditional Name | (1S,2R,10R,11S,14R,15S)-14-hydroxy-14-[(1S)-1-hydroxyethyl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one |
---|
CAS Registry Number | 652-69-7 |
---|
SMILES | [H][C@@]12CC[C@](O)([C@H](C)O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C |
---|
InChI Identifier | InChI=1S/C21H32O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12-13,16-18,22,24H,4-11H2,1-3H3/t13-,16+,17-,18-,19-,20-,21-/m0/s1 |
---|
InChI Key | MASCESDECGBIBB-HNXXTFFGSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Pregnane steroids |
---|
Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Progestogin-skeleton
- 20-hydroxysteroid
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- 1,2-diol
- Cyclic ketone
- Secondary alcohol
- Ketone
- Hydrocarbon derivative
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | - 17,20-dihydroxypregn-4-en-3-one (CHEBI:16418 )
- C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives (LMST02030183 )
|
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|